The Nifty Pharma index surged to a record high of 22,587.95 on Wednesday, outperforming the Nifty 50 benchmark by rising 10% over the past month. Divi’s Laboratories led the gains, climbing 3.76% following a favorable US court ruling on a drug. Other major contributors, including Dr. Reddy’s Laboratories, Glenmark Pharma, Zydus Life, and IPCA Labs, […]Continue Reading
